Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Stoitzner

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Investigative Dermatology|January 25, 2003
Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207Patrizia Stoitzner, Sandra Holzmann, Alexander D McLellan, et al.
Cancer Immunology, Immunotherapy : CII|December 4, 2020
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytesLukas Peiffer, Farnoush Farahpour, Ashwin Sriram, et al.
Oncoimmunology|March 28, 2017
Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesisDaniela Ortner, Christoph H Tripp, Kerstin Komenda, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 16, 2020
Combining chemotherapy and autologous peptide-pulsed dendritic cells provides survival benefit in stage IV melanoma patientsKlaus Eisendle, Georg Weinlich, Susanne Ebner, et al.
International Journal of Cancer|November 9, 2019
A TLR7 agonist strengthens T and NK cell function during BRAF-targeted therapy in a preclinical melanoma modelLydia Bellmann, Giuseppe Cappellano, Johanna F Schachtl-Riess, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skinGudrun Ratzinger, Patrizia Stoitzner, Susanne Ebner, et al.
The Journal of Investigative Dermatology|November 6, 2009
Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermisVincent Flacher, Christoph H Tripp, Patrizia Stoitzner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2014
NK cells are required for dendritic cell-based immunotherapy at the time of tumor challengeAnthea L Bouwer, Sarah C Saunderson, Felicity J Caldwell, et al.
Frontiers in Immunology|July 25, 2012
Expression of XCR1 Characterizes the Batf3-Dependent Lineage of Dendritic Cells Capable of Antigen Cross-PresentationAnnabell Bachem, Evelyn Hartung, Steffen Güttler, et al.
Experimental Dermatology|May 9, 2025
Blocking of IL-4/IL-13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton SyndromeStefan Blunder, Natascha Hermann-Kleiter, Rita Mahmuti, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Investigative Dermatology|January 25, 2003
Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207Patrizia Stoitzner, Sandra Holzmann, Alexander D McLellan, et al.
Cancer Immunology, Immunotherapy : CII|December 4, 2020
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytesLukas Peiffer, Farnoush Farahpour, Ashwin Sriram, et al.
Oncoimmunology|March 28, 2017
Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesisDaniela Ortner, Christoph H Tripp, Kerstin Komenda, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 16, 2020
Combining chemotherapy and autologous peptide-pulsed dendritic cells provides survival benefit in stage IV melanoma patientsKlaus Eisendle, Georg Weinlich, Susanne Ebner, et al.
International Journal of Cancer|November 9, 2019
A TLR7 agonist strengthens T and NK cell function during BRAF-targeted therapy in a preclinical melanoma modelLydia Bellmann, Giuseppe Cappellano, Johanna F Schachtl-Riess, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skinGudrun Ratzinger, Patrizia Stoitzner, Susanne Ebner, et al.
The Journal of Investigative Dermatology|November 6, 2009
Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermisVincent Flacher, Christoph H Tripp, Patrizia Stoitzner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2014
NK cells are required for dendritic cell-based immunotherapy at the time of tumor challengeAnthea L Bouwer, Sarah C Saunderson, Felicity J Caldwell, et al.
Frontiers in Immunology|July 25, 2012
Expression of XCR1 Characterizes the Batf3-Dependent Lineage of Dendritic Cells Capable of Antigen Cross-PresentationAnnabell Bachem, Evelyn Hartung, Steffen Güttler, et al.
Experimental Dermatology|May 9, 2025
Blocking of IL-4/IL-13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton SyndromeStefan Blunder, Natascha Hermann-Kleiter, Rita Mahmuti, et al.
Pageof 10